Nu Skin/$NUS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Nu Skin
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
Ticker
$NUS
Sector
Primary listing
NYSE
Employees
3,100
Headquarters
Website
Nu Skin Metrics
BasicAdvanced
$509M
5.07
$2.03
0.89
$0.24
2.33%
Price and volume
Market cap
$509M
Beta
0.89
52-week high
$14.62
52-week low
$5.32
Average daily volume
600K
Dividend rate
$0.24
Financial strength
Current ratio
2.013
Quick ratio
1.147
Long term debt to equity
35.003
Total debt to equity
39.446
Dividend payout ratio (TTM)
11.83%
Interest coverage (TTM)
5.27%
Profitability
EBITDA (TTM)
157.999
Gross margin (TTM)
69.61%
Net profit margin (TTM)
6.20%
Operating margin (TTM)
5.89%
Effective tax rate (TTM)
14.19%
Revenue per employee (TTM)
$520,000
Management effectiveness
Return on assets (TTM)
3.95%
Return on equity (TTM)
13.68%
Valuation
Price to earnings (TTM)
5.071
Price to revenue (TTM)
0.314
Price to book
0.65
Price to tangible book (TTM)
0.77
Price to free cash flow (TTM)
8.716
Free cash flow yield (TTM)
11.47%
Free cash flow per share (TTM)
1.181
Dividend yield (TTM)
2.33%
Forward dividend yield
2.33%
Growth
Revenue change (TTM)
-11.79%
Earnings per share change (TTM)
-167.83%
3-year revenue growth (CAGR)
-13.12%
10-year revenue growth (CAGR)
-3.62%
3-year earnings per share growth (CAGR)
-2.94%
10-year earnings per share growth (CAGR)
-4.59%
3-year dividend per share growth (CAGR)
-46.07%
10-year dividend per share growth (CAGR)
-16.11%
What the Analysts think about Nu Skin
Analyst ratings (Buy, Hold, Sell) for Nu Skin stock.
Bulls say / Bears say
Q2 2025 EPS of $0.43 topped the analyst estimate of $0.24, demonstrating robust cost control and operational resilience amid revenue pressures. (GuruFocus)
Rhyz Manufacturing segment posted 17% year-over-year revenue growth, underscoring the success of Nu Skin’s vertically integrated manufacturing strategy. (GuruFocus)
Latin America region revenue surged 107% year-over-year, highlighting strong market execution and potential for further expansion in emerging markets. (Company Press Release)
Total Q2 2025 revenue fell 12.1% year-over-year to $386.1 million, indicating ongoing challenges in Nu Skin’s core direct-selling business. (Reuters)
Customers declined by 14%, paid affiliates by 16%, and sales leaders by 23% year-over-year in Q2 2025, signaling weakening distribution network dynamics. (Reuters)
Mainland China segment revenue dropped 17.7% year-over-year in Q2 2025, raising concerns about recovery prospects in a key market. (Nasdaq)
Data summarised monthly by Lightyear AI. Last updated on 2 Oct 2025.
Nu Skin Financial Performance
Revenues and expenses
Nu Skin Earnings Performance
Company profitability
Nu Skin News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Nu Skin stock?
Nu Skin (NUS) has a market cap of $509M as of October 13, 2025.
What is the P/E ratio for Nu Skin stock?
The price to earnings (P/E) ratio for Nu Skin (NUS) stock is 5.07 as of October 13, 2025.
Does Nu Skin stock pay dividends?
Yes, the Nu Skin (NUS) stock pays dividends to shareholders. As of October 13, 2025, the dividend rate is $0.24 and the yield is 2.33%. Nu Skin has a payout ratio of 11.83% on a trailing twelve-month basis.
When is the next Nu Skin dividend payment date?
The next Nu Skin (NUS) dividend payment date is unconfirmed.
What is the beta indicator for Nu Skin?
Nu Skin (NUS) has a beta rating of 0.89. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.